Researchers have created a prototype oral flu vaccine, which unlike standard inoculations does not need to be stored in a fridge or freezer.
While there is a need for Lassa fever virus and Middle East respiratory syndrome (MERS) vaccines, there isn’t enough of a commercial market to induce pharmaceutical companies to develop them.
The synthetic technology breakthrough points to safer vaccines.
This new approach to vacccines could help curtail hospitalizations due to influenza infection.
The Imperial College London center will aim to speed up development of vaccines.
Vaccines world 2017 will create a forum to improve knowledge translation to identify, discuss and troubleshoot the current vaccine and immunology related issues across a range of disciplines and tracks.
Scientists hijacked the tobacco plant's metabolism to turn the leaves into polio-vaccine factories.
The University of Plymouth has launched a spin out company to address new vaccines for diseases which spread from animals to humans.
The technology has the potential to mass produce antibodies in the lab to supplement real immune systems that are compromised, or battling pathogens.
Developing vaccines is expensive and still does not guarantee that people who need them can get them.